You are here: Industry Insights > J&J

News List

US gives EUA J&J’s COVID-19 vaccine expresspharma
March 01, 2021
In J&J’s 44,000-person global trial, the vaccine was found to be 66 per cent effective at preventing moderate-to-severe COVID-19 four weeks after inoculation.
FDA finds J&J’s single-dose Covid-19 vaccine safe and effective in trials pharmaceutical-technology
February 26, 2021
The US Food and Drug Administration (FDA) said that Johnson & Johnson’s single-shot Covid-19 vaccine, Ad26.COV2.S is safe and effective, according to the data submitted from its ongoing Phase III trials.
J&J Announces Single-Shot Janssen COVID-19 Vaccine Candidate Submission to WHO americanpharmaceuticalreview
February 23, 2021
Johnson & Johnson announced Janssen-Cilag International has submitted for Emergency Use Listing (EUL) to the World Health Organization (WHO) for the investigational single-dose Janssen COVID-19 vaccine candidate.
Janssen-Cilag seeks EMA authorisation for Covid-19 vaccine candidate pharmaceutical-technology
February 19, 2021
Johnson & Johnson’s (J&J) Janssen-Cilag International has announced it applied to the European Medicines Agency (EMA) to obtain authorisation for its Covid-19 vaccine candidate.
J&J to bring COVID-19 vaccine to India in partnership with Biological E expresspharma
February 10, 2021
Biological E has said it can produce 600 million doses for J&J and more than one billion doses a year of its own vaccine, developed with Baylor College of Medicine and Dynavax Technologies Corp.
J&J’s COVID-19 vaccine best used to curb outbreak, Novavax’s vaccine for overall protection: GlobalData expresspharma
February 01, 2021
As countries increasingly have weapons against COVID-19 in their armamentarium, increased scrutiny will be placed on the fifth, sixth, and later vaccines to enter the market.
South Africa to get nine million doses of J&J vaccine: Business Day expresspharma
January 19, 2021
South Africa, which has yet to receive its first coronavirus vaccine, has been promised nine million doses by Johnson & Johnson, the Business Day newspaper reported, citing a health ministry spokeswoman.
European Commission scores 200 million doses of J&J’s potential COVID-19 vaccine pharmatimes
October 10, 2020
The European Commission, acting on behalf of the European Union member states, has approved an advanced purchase agreement for 200 million doses of J&J’s COVID-19 vaccine.
J&J to provide 200,000 Ebola vaccine regimens to Rwanda europeanpharmaceuticalreview
December 10, 2019
Johnson & Johnson has announced that it will be contributing vaccines to support the Rwandan immunisation programme to combat Ebola.
J&J commits $500M investment to end TB, HIV biospectrumasia
October 08, 2019
As part of the $500 million investment, Janssen will continue to advance an investigational mosaic-based vaccine regimen to prevent HIV together with a consortium of partners.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page